Citra-Lock™ S (trisodium citrate)

Product category 

Therapy area 

  • Renal
  • Oncology

Citra-Lock™ S (trisodium citrate): Anticoagulant and Antimicrobial catheter lock solution to help maintain catheter patency, prevent catheter related infections and reduce biofilm formation.

The range of pre-filled syringes contain trisodium citrate locking solution in 30% & 46.7% strengths.

Citra-Lock™ 30% and 46.7% can significantly reduce the amount of Urokinase used in haemodialysis units1,2

Citra-Lock™ 30% has been shown to work more effectively than TauroLock™/ Heparin solution in maintaining effective blood flow rates2

Downloads: 

References:

  1. Legaac R, Catheter Care Management in Haemodialysis, European Nephrology, 2011;5(2):138–42
  2. Sanchez R & Dean S, Our experience using Citra-Lock™ 30% to maintain the patency of permanent tunnelled vascular catheter, poster at BRS 2012
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Syner-Med (Pharmaceutical Products) Limited. Tel. +44 020 8655 6380

Leave us a message

CONTACT US

International headquarters
Syner-Med (Pharmaceutical Products) Ltd.
Syner-Med House
120 High Street
Purley, Surrey
CR8 2AD, United Kingdom

Tel: +44 (0)20 8655 6380
E: mail@syner-med.com

Are you a healthcare professional?

To access this section of the Syner-Med Pharmaceutical Products Limited website you need to be a member of the healthcare profession because the materials included in this area of our website are specifically prepared for that audience only.

Please click on the appropriate button below to confirm that you are a healthcare professional. If you are not a healthcare professional, you will be taken to an area of the website that is appropriate for you.

I am a healthcare professional

I am not a healthcare professional